In this episode of PodBites, Rafah Chahine and Raghda Adwan break down the pharmacological management of peptic ulcer disease (PUD)—a condition caused by an imbalance between stomach acid and protective mechanisms. They explore antacids, acid-suppressing agents, mucosal protective drugs, and H. pylori eradication therapies, explaining their mechanisms, uses, and side effects.
✔️ What are peptic ulcers? Causes, symptoms, and risk factors.
✔️ Acid control strategies: Antacids, H2 receptor antagonists, and proton pump inhibitors (PPIs), including Vonoprazan.
✔️ Mucosal protective agents: Sucralfate, misoprostol, and colloidal bismuth compounds.
✔️ H. pylori eradication: Triple therapy vs. sequential therapy, and strategies to overcome antibiotic resistance.
✔️ Practice questions & high-yield clinical pearls to reinforce key concepts.
Perfect for medical students, residents, and healthcare professionals, this episode simplifies PUD pharmacology into an engaging and digestible discussion.
📩 We’d love to hear your feedback about our PodBites! Let us know your thoughts by filling out this form:
🔗 https://forms.gle/Bufb7dLMTckV5M13A
🎧 Tune in now and upgrade your understanding of PUD treatment!